15 results
425
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Business combination disclosure
9:38am
) the fees and expenses incurred in connection with the engagement and services of the Exchange Agent, (F) any filing fees payable in respect … Company Workers who work in the United States are, and all former Company Workers who worked in the United States whose engagement terminated, voluntarily
8-K
EX-10.6
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
that prior to the Anniversary Date, Consultant terminates this Agreement for any reason or the Company terminates Consultant’s engagement other than
8-K
EX-10.5
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
,
As recognition of your important role at Reneo Pharmaceuticals, Inc. (the “Company”), and to incentivize your continued engagement and employment through 2024
8-K
EX-2.1
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
amendments or supplements thereto and paid to a financial printer or the SEC, (E) the fees and expenses incurred in connection with the engagement … Company Workers who worked in the United States whose engagement terminated, voluntarily or involuntarily, within the three years prior to the date
8-K
EX-10.1
RPHM
Reneo Pharmaceuticals Inc
5 May 23
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:33pm
for the Engagement Letters, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder’s fee or other fee … in Section 6.1.
7.11 “Engagement Letters” mean each of the engagement letters by and between the Company and the Placement Agents, each dated on or about
DEF 14A
teub6 lfz
22 Apr 22
Definitive proxy
4:05pm
10-K
EX-10.12
9y3oj5fs
23 Mar 22
Annual report
4:38pm
8-K
EX-3.2
v4zgvmej
13 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:36pm
424B4
10w4blaxy6hf4e0sr9
9 Apr 21
Prospectus supplement with pricing info
4:41pm
S-1/A
fjg1xerctyr5ol6ln8
5 Apr 21
IPO registration (amended)
9:12am
S-1
EX-10.8
fkqgddv4ibc
19 Mar 21
IPO registration
5:27pm
S-1
EX-3.3
ij64gnnx zd5ckaetf
19 Mar 21
IPO registration
5:27pm
S-1
EX-3.4
tyfac9ni 66y3z
19 Mar 21
IPO registration
5:27pm
S-1
r0um5063
19 Mar 21
IPO registration
5:27pm
- Prev
- 1
- Next